Using CoreValve for TAVI procedures, a 3.2% low rate of SVD was observed in our registry, none of them requiring reintervention. These findings appear reassuring in term of TAVI 5-year durability. However, results of ongoing large randomized trials with long-term follow-up are needed before extending the indication to TAVI for low-risk young patients

Transcatheter aortic valve implantation with core valve prosthesis: five year durability / Carrabba, N; Ciatti, F; Berteotti, M; Taborchi, G; Ceschia, N; Migliorini, A; Stefano, P; Marchionni, N; Valenti, R. - In: EUROPEAN HEART JOURNAL SUPPLEMENTS. - ISSN 1520-765X. - ELETTRONICO. - 21:(2019), pp. J203-J204.

Transcatheter aortic valve implantation with core valve prosthesis: five year durability

Carrabba, N;Ciatti, F;Berteotti, M;Taborchi, G;Ceschia, N;Stefano, P;Marchionni, N;
2019

Abstract

Using CoreValve for TAVI procedures, a 3.2% low rate of SVD was observed in our registry, none of them requiring reintervention. These findings appear reassuring in term of TAVI 5-year durability. However, results of ongoing large randomized trials with long-term follow-up are needed before extending the indication to TAVI for low-risk young patients
2019
Goal 3: Good health and well-being for people
Carrabba, N; Ciatti, F; Berteotti, M; Taborchi, G; Ceschia, N; Migliorini, A; Stefano, P; Marchionni, N; Valenti, R
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1207391
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact